Effect of ponsinomycin on cyclosporin pharmacokinetics
โ Scribed by W. Couet; B. Istin; P. Seniuta; D. Morel; L. Potaux; J. B. Fourtillan
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 284 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
โฆ Synopsis
The influence of treatment with ponsinomycin, a new macrolide antibiotic, on the pharmacokinetics of cyclosporin A has been studied in 10 renal transplant patients. The pharmacokinetics of cyclosporin A was investigated at steady state, before and during treatment with ponsinomycin. On average, the blood levels of cyclosporin A were doubled by the macrolide, possibly due to a decrease in elimination or/and to an increase in absorption. Ponsinomycin should be use very carefully in patients treated with cyclosporin A.
๐ SIMILAR VOLUMES
Abbreviations: AUC, area under the curve; AUC 0-1 , area under the curve from time 0 to infinity; CI, confidence interval(s); CL/F, apparent clearance; C max , maximum concentration; CRU, Clinical Research Unit; CYP3A, cytochrome P450 3A; DN, dose-normalized; F, oral bioavailability; GLS mean ratio(
The effect of IntralipidTM co-administration on the pharmacokinetics of cyclosporine (CyA) was studied in NZW rabbits. A single intravenous bolus dose of CyA (10mg kg-') mixed with 3 ml of Intralipid was administered to rabbits (n = 4). Control animals (n = 4) received the same dose of CyA without I
Departments of Pediatrics nnd Sure( r\ The I ' R I L rrsitv of C'hicago Pritzker Srhool of Medicine, The Wder Children ' . s Hospital, A major factor in poor bioavailability of cyclosporine in children undergoing orthotopic liver transplantation appears to be poor absorption of the drug. Our hypothe